YD Bio (YDES) Income Statement (2023 - 2025)
Annual Income Statement report data from Dec 31, 2023 to Dec 31, 2025 for YD Bio (YDES).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Revenue and COGS | |||
Total Revenue | 600K (+17.65%) | 510K (+45.71%) | 350K |
Cost Of Revenue | 430K (+19.44%) | 360K (+80.00%) | 200K |
Costof Goods And Services Sold | 430K (+19.44%) | 360K (+80.00%) | 200K |
Gross Profit | 170K (+6.25%) | 160K (+6.67%) | 150K |
Operating Expenses | |||
Research And Development | 1.60M (+226.53%) | 490K | - |
Selling General And Administrative | 3.66M (+226.79%) | 1.12M (+646.67%) | 150K |
Operating Expenses | 5.44M (+235.80%) | 1.62M (+912.50%) | 160K |
Depreciation And Amortization | 20K (+100.00%) | 10K | - |
Operating Income | |||
Operating Income | -5.27M (+260.96%) | -1.46M (+14500.00%) | -10.00K |
Ebit | -5.27M (+260.96%) | -1.46M (+14500.00%) | -10.00K |
EBITDA | -5.26M (+262.76%) | -1.45M (+14400.00%) | -10.00K |
Other Income / Expenses | |||
Interest Income | 80K (+700.00%) | 10K | - |
Net Interest Income | 80K (+700.00%) | 10K | - |
Other Non Operating Income | 50K (-16.67%) | 60K (+100.00%) | 30K |
Net Income | |||
Income Before Tax | -8.31M (+497.84%) | -1.39M | 20K |
Income Tax Expense | - | 30K | - |
Net Income From Continuing Operations | -8.31M (+489.36%) | -1.41M | 10K |
Net Income | -8.31M (+489.36%) | -1.41M | 10K |
Comprehensive Income Net Of Tax | -8.14M (+477.30%) | -1.41M | 10K |